EE125 Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Immunization Using Monoclonal Antibodies (mAB) in United States Infants: An Analysis of In-Season and out-of-Season Birth Cohorts
Abstract
Authors
D Hariharan AT Farid DS Shepard